/MIRO
MIRO Stock - Miromatrix Medical Inc.
Healthcare|BiotechnologyNASDAQ
$3.39+0.59%
+$0.02 (+0.59%) • Dec 12
90
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
High Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+165.5%upside
Target: $9.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MIRO
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$3.36 – $3.42
TARGET (TP)$9.00
STOP LOSS$3.12
RISK/REWARD1:20.8
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.01
52W High$4.35
52W Low$0.91
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|
| Revenue | $953,470 | $33,066 | $46,530 | $250,000 |
| Gross Profit | $453,470 | $-466,934 | $-453,470 | N/A |
| Gross Margin | 47.6% | -1412.1% | -974.6% | 0.0% |
| Operating Income | $-30,245,734 | $-16,959,530 | $-10,258,548 | $-8,991,664 |
| Net Income | $-30,007,832 | $-14,955,736 | $-8,716,348 | $-3,070,184 |
| Net Margin | -3147.2% | -45230.0% | -18732.7% | -1228.1% |
| EPS | $-1.45 | $-0.73 | $-0.82 | $-0.29 |
Company Overview
Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
MIROBeat Rate
30%
Last 10 quarters
Avg Surprise
-62.9%
EPS vs Estimate
Beats / Misses
3/7
Last 12 quarters
Latest EPS
$-0.24
Q4 2023
EPS Surprise History
Q1 22
-80.0%
$-0.27vs$-0.15
Q2 22
-20.7%
$-0.35vs$-0.29
Q3 22
-21.2%
$-0.40vs$-0.33
Q4 22
-12.1%
$-0.37vs$-0.33
Q1 23
+10.8%
$-0.33vs$-0.37
Q2 23
+2.9%
$-0.33vs$-0.34
Q3 23
+25.0%
$-0.24vs$-0.32
Q4 23
-33.3%
$-0.24vs$-0.18
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Aug 12, 2024 | — | — | — | — |
Q2 2024 | May 9, 2024 | — | — | — | — |
Q1 2024 | Mar 29, 2024 | $-0.18 | — | — | — |
Q4 2023 | Nov 14, 2023 | $-0.18 | $-0.24 | -33.3% | ✗ MISS |
Q3 2023 | Aug 14, 2023 | $-0.32 | $-0.24 | +25.0% | ✓ BEAT |
Q2 2023 | May 11, 2023 | $-0.34 | $-0.33 | +2.9% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $-0.37 | $-0.33 | +10.8% | ✓ BEAT |
Q4 2022 | Nov 14, 2022 | $-0.33 | $-0.37 | -12.1% | ✗ MISS |
Q3 2022 | Aug 15, 2022 | $-0.33 | $-0.40 | -21.2% | ✗ MISS |
Q2 2022 | May 16, 2022 | $-0.29 | $-0.35 | -20.7% | ✗ MISS |
Q1 2022 | Mar 30, 2022 | $-0.15 | $-0.27 | -80.0% | ✗ MISS |
Q4 2021 | Nov 15, 2021 | $-0.13 | $-0.25 | -92.3% | ✗ MISS |
Q3 2021 | Aug 12, 2021 | $-0.25 | $-1.27 | -408.0% | ✗ MISS |
Q1 2021 | Mar 31, 2021 | — | $-0.02 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.10 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.28 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.31 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.28 | — | — |
Latest News
Loading news...
Frequently Asked Questions about MIRO
What is MIRO's current stock price?
Miromatrix Medical Inc. (MIRO) is currently trading at $3.39 per share. The stock has moved +0.59% today.
What is the analyst price target for MIRO?
The average analyst price target for MIRO is $9.00, based on 1 analyst.
What sector is Miromatrix Medical Inc. in?
Miromatrix Medical Inc. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is MIRO's market cap?
Miromatrix Medical Inc. has a market capitalization of $0.09 billion, making it a small-cap company.
Does MIRO pay dividends?
No, Miromatrix Medical Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAADI
Aadi Bioscience, Inc.
$2.05
Mkt Cap: $0.1B
BLI
Berkeley Lights, Inc.
$1.20
Mkt Cap: $0.1B
CYT
Cyteir Therapeutics, Inc.
$3.02
Mkt Cap: $0.1B
HLVX
HilleVax, Inc.
$2.09
Mkt Cap: $0.1B
IGMS
IGM Biosciences, Inc.
$1.27
Mkt Cap: $0.1B
IMDX
Insight Molecular Diagnostics Inc.
$5.41
Mkt Cap: $0.2B
JBIO
Jade Biosciences, Inc.
$17.03
Mkt Cap: $0.6B
JNCE
Jounce Therapeutics, Inc.
$1.88
Mkt Cap: $0.1B
OPNT
Opiant Pharmaceuticals, Inc.
$20.65
Mkt Cap: $0.1B
RVLP
RVL Pharmaceuticals plc
$0.03
Mkt Cap: $0.0B
Explore stocks similar to MIRO for comparison